Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer This randomized phase Ib ...
In a note to investors on Sunday, analysts at Leerink Partners called these findings “compelling,” adding that they indicate ...
MedPage Today on MSN
Gene Therapy Restores Hearing for Rare Cause of Congenital Deafness
A novel gene therapy enabled children with congenital deafness due to otoferlin (OTOF) gene variants to hear for the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback